External Validation of a Survival Score for Limited-Stage Small Cell Lung Cancer Patients Treated with Chemoradiotherapy.
Lukas KäsmannReem AbdoChukwuka EzeMaurice DantesJulian TaugnerKathrin GennenOlarn RoengvoraphojDirk RadesClaus BelkaFarkhad ManapovPublished in: Lung (2020)
The score was reproducible to estimate the 2-year survival rate of patients with LS-SCLC, especially in the high- and intermediate-risk subgroups. In order to improve the differentiation between patients with an intermediate and favorable survival prognosis, the scoring system needs further development.